316 related articles for article (PubMed ID: 37410892)
1. The pathogenesis of multiple sclerosis: a series of unfortunate events.
van Noort JM; Baker D; Kipp M; Amor S
Clin Exp Immunol; 2023 Dec; 214(1):1-17. PubMed ID: 37410892
[TBL] [Abstract][Full Text] [Related]
2. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Otto C; Hofmann J; Ruprecht K
Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus and Multiple Sclerosis.
Houen G; Trier NH; Frederiksen JL
Front Immunol; 2020; 11():587078. PubMed ID: 33391262
[TBL] [Abstract][Full Text] [Related]
4. Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil.
Pereira JG; Leon LAA; de Almeida NAA; Raposo-Vedovi JV; Fontes-Dantas FL; Farinhas JGD; Pereira VCSR; Alves-Leon SV; de Paula VS
Mult Scler Relat Disord; 2023 Aug; 76():104747. PubMed ID: 37267685
[TBL] [Abstract][Full Text] [Related]
5. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
Ruprecht K
Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
[No Abstract] [Full Text] [Related]
6. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
[TBL] [Abstract][Full Text] [Related]
7. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
Front Immunol; 2021; 12():757302. PubMed ID: 34790199
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
10. Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis.
Hassani A; Reguraman N; Shehab S; Khan G
Front Immunol; 2021; 12():764937. PubMed ID: 34899715
[TBL] [Abstract][Full Text] [Related]
11. Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.
Nourbakhsh B; Cordano C; Asteggiano C; Ruprecht K; Otto C; Rutatangwa A; Lui A; Hart J; Flanagan EP; James JA; Waubant E
Ann Neurol; 2021 Jun; 89(6):1234-1239. PubMed ID: 33704815
[TBL] [Abstract][Full Text] [Related]
12. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
Veroni C; Aloisi F
Front Immunol; 2021; 12():665718. PubMed ID: 34305896
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Willis SN; Stadelmann C; Rodig SJ; Caron T; Gattenloehner S; Mallozzi SS; Roughan JE; Almendinger SE; Blewett MM; Brück W; Hafler DA; O'Connor KC
Brain; 2009 Dec; 132(Pt 12):3318-28. PubMed ID: 19638446
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and multiple sclerosis.
Soldan SS; Lieberman PM
Nat Rev Microbiol; 2023 Jan; 21(1):51-64. PubMed ID: 35931816
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and multiple sclerosis.
Pohl D
J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
[TBL] [Abstract][Full Text] [Related]
16. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
[TBL] [Abstract][Full Text] [Related]
17. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
[TBL] [Abstract][Full Text] [Related]
18. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
[TBL] [Abstract][Full Text] [Related]
19. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Rousseau BA; Bhaduri-McIntosh S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
